• Regulatory NewsRegulatory News

    China FDA Seeks Input on Draft Regulation Tightening Control of Online Drug Sales

    The China Food and Drug Administration (CFDA) has released for public consultation a draft regulation that would tighten control of online sales of food and drugs. The rule will drug prohibit producers and wholesalers to sell products to online consumers, and will require sellers of food, health food, cosmetics, and medical apparatus and instruments to obtain permits. CFDA will crack down on false advertising, and information about certain drugs, including stu...
  • New Bill Hopes to Curb Drug Shortages, Price Gouging

    • 23 May 2012
    A new bill proposed by Rep. Elijiah Cummings aims to curb drug shortages resulting from so-called "gray market" drug sales where companies purchase stock of medicines experiencing shortages and exorbitantly mark up prices to subsequent purchasers. "Nobody should be allowed to engage in profiteering at the expense of children and adults with cancer or other critical illnesses by jacking up the price of drugs that are in critically short supply," said Cummings.  ...
  • Rising UK Drug Shortages Highlight MHRA's Oversight Problems

    The UK is facing increasing shortages of vital medicines as supplies are exported to other countries in the EU in a case of medicinal pricing arbitrage, reports Reuters . Other countries in the EU are willing to purchase the drug for more than UK purchasing groups are, which is causing parallel trade to occur and drug shortages to emerge. While the case is hardly unique to Britain-Greece is also suffering the effects of parallel trade after austerity measures slashes r...
  • After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

    The US Food and Drug Administration (FDA) is going after doctors in an attempt to protect the pharmaceutical supply chain from more instances of counterfeit medicines, reports Medscape News . There have been two instances of fake Avastin being found in the US in 2012-one in early April and another in mid-February . Both cases involved doctors deviating from approved suppliers to purchase Avastin from unauthorized wholesalers. While FDA Commissioner Margaret Hamburg ...
  • Report: Second Instance of Fake Avastin Highlights MHRA Troubles

    Another incident involving lots of fake bevacizumab (Avastin/Altuzan)-the second in as many months-is drawing attention to resource shortages at the UK's Medicines and Healthcare product Regulatory Agency (MHRA), reports Reuters . The British healthcare product regulator currently oversees 1,800 wholesalers in the country-second in amount only to Germany, which oversees more than 3,000 wholesalers. "We are concerned that the MHRA doesn't have sufficient resources to in...